Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesProspective study of neuropsychiatric events in systemic lupus erythematosus
Journal of Rheumatology, 07/02/09
Hanly JG et al. – The association of lower health-related quality of life (HRQOL) with neuropsychiatric (NP) events over time, independent of progression in cumulative organ damage, emphasizes the persistent negative effect of NP events for pts with systemic lupus erythematosus (SLE).
Methods- Prospective study of NP events and their association with HRQOL over time in SLE pts
- Observational cohort study from single academic center for NP events and their attribution at enrollment and at annual assessments for up to 7 yrs
- NP events characterized by American College of Rheumatology case definitions
- Other variables: global SLE disease activity and cumulative organ damage
- Outcomes of NP events recorded and self-report HRQOL measured by mental (MCS) and physical (PCS) component summary scores of Medical Outcomes Study Short Form-36
- Of 209 pts: 88% female; 92% Caucasian, mean (SD) age 43.7 (13.8) yrs
- Follow-up for 175/209 (84%) pts
- Over mean follow-up of 3.6 (2.5) yrs, 299 NP events in 132/209 (63%) pts
- NP events attributed to SLE: 31% in 54 pts
- On multivariate analysis, lower MCS scores in pts with NP events vs those without events regardless of attribution
- Group means for PCS scores significantly lower in pts with NP events regardless of attribution
- No association between HRQOL and cumulative organ damage nor between NP events and organ damage progression
Today in Systemic Lupus (SLE)...keeping you current
Receive free subspecialty "5-minute updates" via email
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial
Annals of Rheumatic Diseases, 11/10/09
Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study
Rheumatology, 11/24/09
Sponsor
Article Search
Sponsor